Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TNFSF18 Antikörper

Der Kaninchen Polyklonal anti-TNFSF18 Antikörper (ABIN1169328) detektiert spezifisch TNFSF18 in WB, ELISA und IHC. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN1169328
392,77 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 2 bis 5 Werktagen

Kurzübersicht für TNFSF18 Antikörper (ABIN1169328)

Target

Alle TNFSF18 Antikörper anzeigen
TNFSF18 (Tumor Necrosis Factor (Ligand) Superfamily, Member 18 (TNFSF18))

Reaktivität

  • 73
  • 15
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 67
  • 10
  • 7
Kaninchen

Klonalität

  • 63
  • 20
  • 1
Polyklonal

Konjugat

  • 40
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser TNFSF18 Antikörper ist unkonjugiert

Applikation

  • 49
  • 24
  • 19
  • 14
  • 14
  • 7
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Verwendungszweck

    anti-GITRL (human), pAb

    Spezifität

    Recognizes human GITRL. Detects a band of ~15-17 kDa by Western blot. Does not cross-react with mouse GITRL.

    Keine Kreuzreaktivität

    Maus

    Kreuzreaktivität (Details)

    Does not cross-react with mouse GITRL.

    Produktmerkmale

    Polyclonal Antibody. Recognizes human GITRL. Detects a band of ~15-17 kDa by Western blot. Does not cross-react with mouse GITRL. Source: Rabbit. Applications: ELISA, IHC, WB. Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives. GITRL is expressed on dendritic cells (DC), monocytes, macrophages, B cells, activated T cells, endothelial cells, osteoclasts and various healthy non-lymphoid tissues (e.g. testis, .). GITRL is constitutively expressed and released as soluble form by solid tumors and various hematopoietic malignancies. GITRL causes differentiation of osteoclasts, activation of macrophages, but also alteration of carcinoma and leukemia cells and influences apoptosis. Binding to GITR is important in regulating T-cell proliferation and TCR-mediated apoptosis. GITRL is implicated in development of autoimmune diseases and in the immune response against infectious pathogens and tumors.

    Sterilität

    0.2 μm filtered

    Immunogen

    Recombinant human GITRL.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4.

    Konservierungsmittel

    Without preservative

    Handhabung

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    +4°C

    -20°C

    Stable for at least 6 months after receipt when stored at -20°C.

    Haltbarkeit

    6 months
  • Target

    TNFSF18 (Tumor Necrosis Factor (Ligand) Superfamily, Member 18 (TNFSF18))

    Andere Bezeichnung

    GITRL

    Hintergrund

    Alternate Names/Synonyms: Glucocorticoid-induced TNF Receptor Ligand, AITRL, Activation-inducible TNF-related Ligand, TNFSF18

    Product Description: GITRL is expressed on dendritic cells (DC), monocytes, macrophages, B cells, activated T cells, endothelial cells, osteoclasts and various healthy non-lymphoid tissues (e.g. testis, ..). GITRL is constitutively expressed and released as soluble form by solid tumors and various hematopoietic malignancies. GITRL causes differentiation of osteoclasts, activation of macrophages, but also alteration of carcinoma and leukemia cells and influences apoptosis. Binding to GITR is important in regulating T-cell proliferation and TCR-mediated apoptosis. GITRL is implicated in development of autoimmune diseases and in the immune response against infectious pathogens and tumors.

    UniProt

    Q9UNG2
Sie sind hier:
Chat with us!